Higher levels of inflammatory markers at age 9 linked to an 81% increased risk of developing depression at age 18.

Data from seven randomized controlled trials in people that were ill and depressed showed a significant antidepressant effect of anti-cytokine (anti-inflammatory) treatment compared with placebo. Further analysis showed that the antidepressant effect was not associated with improvement in primary physical illness.